NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Rhea-AI Summary

NeuroOne Medical Technologies (NASDAQ: NMTC), a medical technology company specializing in neurological disorder surgical care solutions, has announced its participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference.

CEO Dave Rosa will deliver a virtual corporate presentation on Wednesday, March 19, 2025, at 9:20 a.m. eastern time. Following the presentation, one-on-one meetings will be available through Oppenheimer. Interested parties can access the live webcast or replay through the provided link or NeuroOne's investor relations website events page.

News Market Reaction – NMTC

+0.93%

+0.93% Session move

In the trading session that priced this news, NMTC gained 0.93%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that it will participate in the upcoming Oppenheimer 35th Annual Healthcare Conference MedTech & Services Conference on Wednesday, March 19, 2025.

NeuroOne CEO Dave Rosa will host a virtual corporate presentation at 9:20 a.m. eastern time on Wednesday, March 19, 2025, followed by one-on-one meetings, which can be requested through Oppenheimer. To join live or view a replay of the webcast, please visit this link or the events page on NeuroOne’s investors relations website.

About NeuroOne
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

IR Contact
Chris Donovan
MZ Group – MZ North America
NMTC@mzgroup.us
(914) 352-5853

FAQ

When is NeuroOne (NMTC) presenting at the Oppenheimer Healthcare Conference 2025?

NeuroOne (NMTC) will present on Wednesday, March 19, 2025, at 9:20 a.m. eastern time.

How can investors watch NeuroOne's (NMTC) Oppenheimer Conference presentation?

Investors can watch the presentation live or view a replay through the webcast link or NeuroOne's investor relations website events page.

Will NeuroOne (NMTC) offer one-on-one meetings at the Oppenheimer Conference?

Yes, one-on-one meetings can be requested through Oppenheimer following the presentation.

What type of conference is NeuroOne (NMTC) participating in?

NeuroOne is participating in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, focusing on healthcare and medical technology.